D.E. Shaw & Co’s Bausch Health BHC Stock Holding History

D.E. Shaw & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-120,000	Closed	-$754K	–	4442
2022 Q4	$754K	Buy	+120,000	New	+$838K	﹤0.01%	3630
2021 Q2	–	Sell	-122,900	Closed	-$3.9M	–	4751
2021 Q1	$3.9M	Sell	122,900 -83,300	-40%	-$2.44M	﹤0.01%	2041
2020 Q4	$4.29M	Sell	206,200 -28,700	-12%	-$535K	﹤0.01%	1987
2020 Q3	$3.65M	Sell	234,900 -26,000	-10%	-$448K	﹤0.01%	1929
2020 Q2	$4.77M	Buy	260,900 +220,600	+547%	+$3.89M	0.01%	1685
2020 Q1	$625K	Sell	40,300 -489,700	-92%	-$11.8M	﹤0.01%	3080
2019 Q4	$15.9M	Buy	530,000 +65,000	+14%	+$1.69M	0.02%	942
2019 Q3	$10.2M	Buy	465,000 +40,000	+9%	+$915K	0.01%	1149
2019 Q2	$10.7M	Sell	425,000 -135,000	-24%	-$3.21M	0.01%	1094
2019 Q1	$13.8M	Sell	560,000 -1,010,000	-64%	-$24.1M	0.02%	915
2018 Q4	$29M	Buy	1,570,000 +135,000	+9%	+$3.21M	0.04%	544
2018 Q3	$36.8M	Sell	1,435,000 -148,200	-9%	-$3.39M	0.04%	507
2018 Q2	$36.8M	Sell	1,583,200 -796,500	-33%	-$16.5M	0.05%	463
2018 Q1	$37.9M	Buy	2,379,700 +770,800	+48%	+$14.3M	0.05%	429
2017 Q4	$33.4M	Sell	1,608,900 -153,200	-9%	-$2.43M	0.05%	469
2017 Q3	$25.3M	Buy	1,762,100 +819,100	+87%	+$12.4M	0.04%	522
2017 Q2	$16.3M	Buy	943,000 +378,400	+67%	+$4.54M	0.03%	673
2017 Q1	$6.23M	Sell	564,600 -1,800,500	-76%	-$24.8M	0.01%	1144
2016 Q4	$34.3M	Sell	2,365,100 -532,200	-18%	-$9.76M	0.06%	426
2016 Q3	$71.1M	Buy	2,897,300 +166,500	+6%	+$4.31M	0.13%	188
2016 Q2	$55M	Buy	2,730,800 +205,800	+8%	+$5.83M	0.1%	237
2016 Q1	$66.4M	Buy	2,525,000 +86,800	+4%	+$6.42M	0.12%	203
2015 Q4	$248M	Buy	2,438,200 +2,273,000	+1,376%	+$255M	0.37%	44
2015 Q3	$29.5M	Buy	165,200 +100,900	+157%	+$23.5M	0.04%	465
2015 Q2	$14.3M	Buy	64,300 +45,800	+248%	+$10.2M	0.02%	798
2015 Q1	$3.67M	Hold	18,500	–	–	0.01%	1577
2014 Q4	$2.65M	Hold	18,500	–	–	﹤0.01%	2045
2014 Q3	$2.43M	Hold	18,500	–	–	﹤0.01%	2089
2014 Q2	$2.33M	Sell	18,500 -33,800	-65%	-$4.31M	﹤0.01%	2189
2014 Q1	$6.89M	Sell	52,300 -34,500	-40%	-$4.72M	0.01%	1312
2013 Q4	$10.2M	Buy	86,800 +26,800	+45%	+$2.94M	0.01%	1130
2013 Q3	$6.26M	Buy	60,000 +35,500	+145%	+$3.46M	0.01%	1392
2013 Q2	$2.11M	Buy	+24,500	New	+$1.93M	﹤0.01%	2064

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's BHC Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Bausch Health (BHC) stake by 63% in Q1 2026, selling an estimated $6.34M and leaving 621,755 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

D.E. Shaw & Co first reported a position in BHC in Q2 2013 and has held it in 48 quarters since. The position peaked at $614M in Q1 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

D.E. Shaw & Co held 621,755 shares of Bausch Health worth $3.36M as of Q1 2026.
D.E. Shaw & Co sold 1,058,874 Bausch Health shares in Q1 2026, an estimated $6.34M.
Bausch Health made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2490 holding.
D.E. Shaw & Co first reported a position in Bausch Health in Q2 2013 and has held it in 48 quarters since.
D.E. Shaw & Co's Bausch Health position peaked at $614M in Q1 2015.
227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.